Live from New York, it's... AffyImmune!
Our friends at Ramp gave us a boost in Times Square, featuring a tweet by Center for Technology Licensing at Cornell about our clinical data from #ASCO23
Thanks to Ramp for the surprise and to our partners helping deliver AIC100 to patients in our clinical trial!
Dr. Javier Cortes MD PhD presented the #PHERGain 3-year disease-free survival results at #ASCO23 and, following The Lancet publication, emphasized the achievements attained in this study.
Learn more about the study: medsir.org/post/revolutio…
#MEDSIRtheLancet #OncologyResearch
GU Cancer Highlights from #ASCO23 w/Toni Choueiri, MD
- #TALAPRO2
- #CLEAR
- #CONTACT03
- #THOR
Full Discussion:
- oncbrothers.com/gu-asco2023/
- Podcast tinyurl.com/OncBro
#gusm ASCO #OncTwitter #MedTwitter Hem-Onc Fellows Network Targeted Oncology #MedEd OncoAlert IMG Oncologists #OncEd
w/Jonathan Friedberg we🗣️2 practice changing📑
- #POLARIX : #Pola 1L DLBCL
- SWOG Cancer Research Network #S1826 : Nivo cHL
Full discussion:
- oncbrothers.com/polarix-swogs1…
- targetedonc.com/pivotal-practi…
- “Oncology Brothers” podcast
#lymsm #HemeTwitter #MedTwitter Targeted Oncology #ASCO23 Journal of Clinical Oncology Wilmot Cancer Institute
Quick break from Cedars-Sinai Genitourinary Oncology Retreat to reflect on #ASTRO23 and thank ASTRO Chair Jeff Michalski for an incredibly Family-Friendly annual meeting!
Our daughters loved their “Future ASTRO Member” badges to match their #ASCO23 ones!
Cancer at Cedars-Sinai Cedars-SinaiMed
Sylvester Comprehensive Cancer Center whirlwind #GrandRounds summer series continues!
This week, Dr. Estela Rodriguez reviews #LCSM #ASCO23 updates, and reminds us about the importance of #BiomarkerTestingforAll to increase access to treatment options
ASCO FLASCO IASLC ACSCAN Florida ACS National Lung Cancer Roundtable
“Somos oncólogos y estamos aquí para curar pacientes” , aunq tu repaso de ASCO23 ha sido inmejorable (como siempre) xa mí esto es lo q +grande te hace# Congrats Javier Cortes MD PhD MamaCentro
Happy #FlashbackFriday ! American Cancer Society (ACS) spoke with CA Editor Don S. Dizon MD (he/him) 🇬🇺 at #ASCO23 on how far we've come in treating patients with cancer over the past 20 years.
Visit our collection of ACS Statistics to learn more about the progress being made:
acsjournals.onlinelibrary.wiley.com/doi/toc/10.332…
Pleased to share The Lancet Oncology LENVA-PEMBRO across RCC variant histologies: papillary RCC, unclRCC and chromophobe RCC … interim ESMO - Eur. Oncology #ESMO22 and final Chung-Han Lee 李宗翰, MD/PhD ASCO #ASCO23
full text: authors.elsevier.com/a/1hP1c5EIIgLp…
Thanks to all who change
rareRCC pts Tx!